New Study Finds Programs Designed to Protect Safety Being Widely Abused, Delaying Generic Choices for Consumers and Costing U.S. Health System Billions
July 23, 2014
July 23, 2014
WASHINGTON, July 23 -- Generic Pharmaceutical Association issued the following news release:
The ongoing abuse of FDA drug safety programs to prevent generic competition is costing the American health care system and patients $5.4 billion in annual pharmaceutical spending that could be saved if 40 drugs examined in a Matrix Global Advisors report released today were allowed to come to market. The study, commissioned by the Generic Pharmaceutical Association, also found that after . . .
The ongoing abuse of FDA drug safety programs to prevent generic competition is costing the American health care system and patients $5.4 billion in annual pharmaceutical spending that could be saved if 40 drugs examined in a Matrix Global Advisors report released today were allowed to come to market. The study, commissioned by the Generic Pharmaceutical Association, also found that after . . .